Chris Tam

Company: Integrated Nanotherapeutics

Job title: Chief Executive Officer

Seminars:

Developing LNP/mRNA Therapeutics to Achieve Antigen-Specific Immune Tolerance 8:00 am

• Highlighting the unique benefits of using a Multi-Cargo LNP approach to deliver autoantigens and modulate the immune system • Discussing the biodistribution and mechanism of LNP/mRNA in inducing immune tolerance • Showcasing the therapeutic potential of LNP/mRNA technology in type 1 diabetes and other autoimmune diseasesRead more

day: Custom Day Two

Panel Discussion: Practical Approaches for Creating a Compelling Preclinical Data Package for IND Submission to Move ASIT Therapies from the Lab to the Clinic 1:00 pm

• Highlighting the importance of robust clinical data to secure funding, partnerships, and regulatory buy-in in a new area with limited proof-of-concept studies • Turbocharging the development of humanized mouse models and organoids to accurately replicate human autoimmune diseases for increased preclinical data • Evaluating strategies for first in-human trials: when and where should the…Read more

day: Custom Day Two